{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:51:55Z","timestamp":1791874315285,"version":"4.3.4"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11033-022-07160-3","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T06:05:51Z","timestamp":1643781951000},"page":"4977-4988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2670-3997","authenticated-orcid":false,"given":"P.","family":"Monika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6702-9324","authenticated-orcid":false,"given":"M. N.","family":"Chandraprabha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"7160_CR1","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1093\/cid\/cir864","volume":"54","author":"KJ Kwon-Chung","year":"2012","unstructured":"Kwon-Chung KJ (2012) Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clin Infect Dis 54:S8\u2013S15. https:\/\/doi.org\/10.1093\/cid\/cir864","journal-title":"Clin Infect Dis"},{"key":"7160_CR2","first-page":"72","volume":"19","author":"R Mohammadi","year":"2014","unstructured":"Mohammadi R, Nazeri M, Amin Sayedayn SM, Ehteram H (2014) A successful treatment of rhinocerebral mucormycosis due to Rhizopus Oryzae. J Res Med Sci 19:72\u201374","journal-title":"J Res Med Sci"},{"key":"7160_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jof5010026","author":"H Prakash","year":"2019","unstructured":"Prakash H, Chakrabarti A (2019) Global epidemiology of Mucormycosis. J Fungi. https:\/\/doi.org\/10.3390\/jof5010026","journal-title":"J Fungi"},{"key":"7160_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/mmy\/myy060","volume":"57","author":"H Prakash","year":"2019","unstructured":"Prakash H, Ghosh AK, Rudramurthy SM et al (2019) A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment. Med Mycol 57:395\u2013402. https:\/\/doi.org\/10.1093\/mmy\/myy060","journal-title":"Med Mycol"},{"key":"7160_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms9030523","volume":"9","author":"H Prakash","year":"2021","unstructured":"Prakash H, Chakrabarti A (2021) Epidemiology of mucormycosis in India. Microorganisms 9:1\u201312. https:\/\/doi.org\/10.3390\/microorganisms9030523","journal-title":"Microorganisms"},{"key":"7160_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.22207\/JPAM.13.1.16","volume":"13","author":"R Suganya","year":"2019","unstructured":"Suganya R, Malathi N, Karthikeyan V, Janagaraj VD (2019) Mucormycosis: a brief review. J Pure Appl Microbiol 13:161\u2013165. https:\/\/doi.org\/10.22207\/JPAM.13.1.16","journal-title":"J Pure Appl Microbiol"},{"key":"7160_CR7","doi-asserted-by":"publisher","first-page":"e533","DOI":"10.1016\/j.ijid.2011.02.005","volume":"15","author":"MD Mignogna","year":"2011","unstructured":"Mignogna MD, Fortuna G, Leuci S et al (2011) Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature. Int J Infect Dis 15:e533\u2013e540. https:\/\/doi.org\/10.1016\/j.ijid.2011.02.005","journal-title":"Int J Infect Dis"},{"key":"7160_CR8","first-page":"243","volume":"47","author":"AR Waldorf","year":"1989","unstructured":"Waldorf AR (1989) Pulmonary defense mechanisms against opportunistic fungal pathogens. Immunol Ser 47:243\u2013271","journal-title":"Immunol Ser"},{"key":"7160_CR9","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1086\/428503","volume":"191","author":"C Gil-Lamaignere","year":"2005","unstructured":"Gil-Lamaignere C, Simitsopoulou M, Roilides E et al (2005) Interferon-\u03b3 and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. J Infect Dis 191:1180\u20131187. https:\/\/doi.org\/10.1086\/428503","journal-title":"J Infect Dis"},{"key":"7160_CR10","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1128\/AAC.01136-07","volume":"52","author":"G Chamilos","year":"2008","unstructured":"Chamilos G, Lewis RE, Lamaris G et al (2008) Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage. Antimicrob Agents Chemother 52:722\u2013724. https:\/\/doi.org\/10.1128\/AAC.01136-07","journal-title":"Antimicrob Agents Chemother"},{"key":"7160_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1172\/JCI111395","volume":"74","author":"AR Waldorf","year":"1984","unstructured":"Waldorf AR, Ruderman N, Diamond RD (1984) Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest 74:150\u2013160. https:\/\/doi.org\/10.1172\/JCI111395","journal-title":"J Clin Invest"},{"key":"7160_CR12","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/infdis\/150.5.752","volume":"150","author":"AR Waldorf","year":"1984","unstructured":"Waldorf AR, Levitz SM, Diamond RD (1984) In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis 150:752\u2013760. https:\/\/doi.org\/10.1093\/infdis\/150.5.752","journal-title":"J Infect Dis"},{"key":"7160_CR13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41564-018-0298-0","volume":"4","author":"B Briard","year":"2019","unstructured":"Briard B, Karki R, Malireddi RKS et al (2019) Fungal ligands released by innate immune effectors promote inflammasome activation during Aspergillus fumigatus infection. Nat Microbiol 4:316\u2013327. https:\/\/doi.org\/10.1038\/s41564-018-0298-0","journal-title":"Nat Microbiol"},{"key":"7160_CR14","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1182\/blood-2003-04-1250","volume":"102","author":"MD Knutson","year":"2003","unstructured":"Knutson MD, Vafa MR, Haile DJ, Wessling-Resnick M (2003) Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 102:4191\u20134197. https:\/\/doi.org\/10.1182\/blood-2003-04-1250","journal-title":"Blood"},{"key":"7160_CR15","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1080\/21505594.2017.1342920","volume":"8","author":"S Wurster","year":"2017","unstructured":"Wurster S, Thielen V, Weis P et al (2017) Mucorales spores induce a proinflammatory cytokine response in human mononuclear phagocytes and harbor no rodlet hydrophobins. Virulence 8:1708\u20131718. https:\/\/doi.org\/10.1080\/21505594.2017.1342920","journal-title":"Virulence"},{"key":"7160_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","volume":"74","author":"I Raphael","year":"2015","unstructured":"Raphael I, Nalawade S, Eagar TN, Forsthuber TG (2015) T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 74:5\u201317. https:\/\/doi.org\/10.1016\/j.cyto.2014.09.011","journal-title":"Cytokine"},{"key":"7160_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.omtm.2018.03.003","volume":"9","author":"P Castillo","year":"2018","unstructured":"Castillo P, Wright KE, Kontoyiannis DP et al (2018) A new method for reactivating and expanding T cells specific for Rhizopus oryzae. Mol Ther Methods Clin Dev 9:305\u2013312. https:\/\/doi.org\/10.1016\/j.omtm.2018.03.003","journal-title":"Mol Ther Methods Clin Dev"},{"key":"7160_CR18","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.3389\/fmicb.2018.03204","volume":"10","author":"S Belic","year":"2019","unstructured":"Belic S, Page L, Lazariotou M et al (2019) Comparative analysis of inflammatory cytokine release and alveolar epithelial barrier invasion in a transwell\u00aebilayer model of mucormycosis. Front Microbiol 10:3204. https:\/\/doi.org\/10.3389\/fmicb.2018.03204","journal-title":"Front Microbiol"},{"key":"7160_CR19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.imbio.2012.10.013","volume":"218","author":"S Schmidt","year":"2013","unstructured":"Schmidt S, Tramsen L, Perkhofer S et al (2013) Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunity. Immunobiology 218:939\u2013944. https:\/\/doi.org\/10.1016\/j.imbio.2012.10.013","journal-title":"Immunobiology"},{"key":"7160_CR20","doi-asserted-by":"publisher","unstructured":"Saeedi P, Petersohn I, Salpea P et al (2019) Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 157:107843. https:\/\/doi.org\/10.1016\/j.diabres.2019.107843","DOI":"10.1016\/j.diabres.2019.107843"},{"key":"7160_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.diabet.2012.01.002","volume":"38","author":"B Rammaert","year":"2012","unstructured":"Rammaert B, Lanternier F, Poir\u00e9e S et al (2012) Diabetes and mucormycosis: a complex interplay. Diabetes Metab 38:193\u2013204. https:\/\/doi.org\/10.1016\/j.diabet.2012.01.002","journal-title":"Diabetes Metab"},{"key":"7160_CR22","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJM199912163412507","volume":"341","author":"N Joshi","year":"1999","unstructured":"Joshi N, Caputo GM, Weitekamp MR, Karchmer AW (1999) Infections in patients with diabetes mellitus. N Engl J Med 341:1906\u20131912. https:\/\/doi.org\/10.1056\/NEJM199912163412507","journal-title":"N Engl J Med"},{"key":"7160_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1034\/j.1600-0420.2001.079001088.x","volume":"79","author":"A Bhansali","year":"2001","unstructured":"Bhansali A, Sharma A, Kashyap A et al (2001) Mucor endophthalmitis. Acta Ophthalmol Scand 79:88\u201390. https:\/\/doi.org\/10.1034\/j.1600-0420.2001.079001088.x","journal-title":"Acta Ophthalmol Scand"},{"key":"7160_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/00365540050166090","volume":"32","author":"G Tsaousis","year":"2000","unstructured":"Tsaousis G, Koutsouri A, Gatsiou C et al (2000) Liver and brain mucormycosis in a diabetic patient type II successfully treated with liposomial amphotericin B. Scand J Infect Dis 32:335\u2013337. https:\/\/doi.org\/10.1080\/00365540050166090","journal-title":"Scand J Infect Dis"},{"key":"7160_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/5845394","volume":"2020","author":"SO Mekki","year":"2020","unstructured":"Mekki SO, Hassan AA, Falemban A et al (2020) Pulmonary Mucormycosis: a case report of a rare infection with potential diagnostic problems. Case Rep Pathol 2020:1\u20134. https:\/\/doi.org\/10.1155\/2020\/5845394","journal-title":"Case Rep Pathol"},{"key":"7160_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0046-8177(80)80054-2","volume":"11","author":"AM Marchevsky","year":"1980","unstructured":"Marchevsky AM, Bottone EJ, Geller SA, Giger DK (1980) The changing spectrum of disease, etiology, and diagnosis of mucormycosis. Hum Pathol 11:457\u2013464. https:\/\/doi.org\/10.1016\/S0046-8177(80)80054-2","journal-title":"Hum Pathol"},{"key":"7160_CR27","doi-asserted-by":"publisher","first-page":"150355","DOI":"10.1016\/J.SCITOTENV.2021.150355","volume":"805","author":"K Pushparaj","year":"2022","unstructured":"Pushparaj K, Kuchi Bhotla H, Arumugam VA et al (2022) Mucormycosis (black fungus) ensuing COVID-19 and comorbidity meets - magnifying global pandemic grieve and catastrophe begins. Sci Total Environ 805:150355. https:\/\/doi.org\/10.1016\/J.SCITOTENV.2021.150355","journal-title":"Sci Total Environ"},{"key":"7160_CR28","doi-asserted-by":"publisher","DOI":"10.23750\/ABM.V92I4.11787","author":"K Ramphul","year":"2021","unstructured":"Ramphul K, Verma R, Kumar N et al (2021) Rising concerns of Mucormycosis (Zygomycosis) among COVID-19 patients; an analysis and review based on case reports in literature. Acta Bio Medica Atenei Parm. https:\/\/doi.org\/10.23750\/ABM.V92I4.11787. 92:","journal-title":"Acta Bio Medica Atenei Parm"},{"key":"7160_CR29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/PIN.12943","volume":"70","author":"Y Fujisawa","year":"2020","unstructured":"Fujisawa Y, Hara S, Zoshima T et al (2020) Fulminant myocarditis and pulmonary cavity lesion induced by disseminated mucormycosis in a chronic hemodialysis patient: Report of an autopsied case. Pathol Int 70:557\u2013562. https:\/\/doi.org\/10.1111\/PIN.12943","journal-title":"Pathol Int"},{"key":"7160_CR30","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/J.DSX.2021.05.019","volume":"15","author":"AK Singh","year":"2021","unstructured":"Singh AK, Singh R, Joshi SR, Misra A (2021) Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr Clin Res Rev 15:102146. https:\/\/doi.org\/10.1016\/J.DSX.2021.05.019","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"7160_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-71908-9","volume":"10","author":"X Lin","year":"2020","unstructured":"Lin X, Xu Y, Pan X et al (2020) Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep 10:1\u201311. https:\/\/doi.org\/10.1038\/s41598-020-71908-9","journal-title":"Sci Rep"},{"key":"7160_CR32","doi-asserted-by":"publisher","first-page":"106031","DOI":"10.1016\/J.IJSU.2021.106031","volume":"92","author":"P Devnath","year":"2021","unstructured":"Devnath P, Dhama K, Tareq AM, Emran T, Bin (2021) Mucormycosis coinfection in the context of global COVID-19 outbreak: a fatal addition to the pandemic spectrum. Int J Surg 92:106031\u2013106031. https:\/\/doi.org\/10.1016\/J.IJSU.2021.106031","journal-title":"Int J Surg"},{"key":"7160_CR33","doi-asserted-by":"publisher","unstructured":"Ahmadikia K, Hashemi SJ, Khodavaisy S et al (2021) The double-edged sword of systemic corticosteroid therapy in viral pneumonia: a case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis. https:\/\/doi.org\/10.1111\/myc.13256. Mycoses","DOI":"10.1111\/myc.13256"},{"key":"7160_CR34","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215121000992","author":"S Sharma","year":"2021","unstructured":"Sharma S, Grover M, Bhargava S et al (2021) Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol. https:\/\/doi.org\/10.1017\/S0022215121000992","journal-title":"J Laryngol Otol"},{"key":"7160_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1298","author":"PL White","year":"2020","unstructured":"White PL, Dhillon R, Cordey A et al (2020) A national strategy to diagnose coronavirus disease 2019\u2013associated invasive fungal disease in the intensive care unit. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa1298","journal-title":"Clin Infect Dis"},{"key":"7160_CR36","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","volume":"185","author":"G Song","year":"2020","unstructured":"Song G, Liang G, Liu W (2020) Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia 185:599\u2013606. https:\/\/doi.org\/10.1007\/s11046-020-00462-9","journal-title":"Mycopathologia"},{"key":"7160_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11046-021-00528-2","volume":"186","author":"D Garg","year":"2021","unstructured":"Garg D, Muthu V, Sehgal IS et al (2021) Coronavirus disease (Covid-19) Associated Mucormycosis (CAM): case report and systematic review of literature. Mycopathologia 186:289\u2013298. https:\/\/doi.org\/10.1007\/s11046-021-00528-2","journal-title":"Mycopathologia"},{"key":"7160_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof6020091","volume":"6","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar A, Carvalho A, van de Veerdonk FL et al (2020) COVID-19 associated pulmonary aspergillosis (CAPA)\u2014from immunology to treatment. J Fungi 6:1\u201317. https:\/\/doi.org\/10.3390\/jof6020091","journal-title":"J Fungi"},{"issue":"66","key":"7160_CR39","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/BF01878266","volume":"663","author":"P F\u00fcrbringer","year":"1876","unstructured":"F\u00fcrbringer P (1876) (1876) Beobachtungen \u00fcber Lungenmycose beim Menschen. Arch f\u00fcr Pathol Anat Physiol f\u00fcr Klin Med 663(66):330\u2013365. https:\/\/doi.org\/10.1007\/BF01878266","journal-title":"Arch f\u00fcr Pathol Anat Physiol f\u00fcr Klin Med"},{"key":"7160_CR40","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","volume":"41","author":"MM Roden","year":"2005","unstructured":"Roden MM, Zaoutis TE, Buchanan WL et al (2005) Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41:634\u2013653. https:\/\/doi.org\/10.1086\/432579","journal-title":"Clin Infect Dis"},{"key":"7160_CR41","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/MYC.12915","volume":"62","author":"Y Madney","year":"2019","unstructured":"Madney Y, Khedr R, Ahmed N et al (2019) Overview and outcome of mucormycosis among children with cancer: report from the Children\u2019s Cancer Hospital Egypt. Mycoses 62:984\u2013989. https:\/\/doi.org\/10.1111\/MYC.12915","journal-title":"Mycoses"},{"key":"7160_CR42","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1080\/17474086.2020.1796624","volume":"13","author":"L Pagano","year":"2020","unstructured":"Pagano L, Dragonetti G, de Carolis E et al (2020) Developments in identifying and managing mucormycosis in hematologic cancer patients. Expert Rev Hematol 13:895\u2013905. https:\/\/doi.org\/10.1080\/17474086.2020.1796624","journal-title":"Expert Rev Hematol"},{"key":"7160_CR43","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/0974-2700.42203","volume":"1","author":"J Pak","year":"2008","unstructured":"Pak J, Tucci VT, Vincent AL et al (2008) Mucormycosis in immunochallenged patients. J Emergencies Trauma Shock 1:106. https:\/\/doi.org\/10.4103\/0974-2700.42203","journal-title":"J Emergencies Trauma Shock"},{"key":"7160_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jinf.2009.06.002","volume":"59","author":"R Ben-Ami","year":"2009","unstructured":"Ben-Ami R, Luna M, Lewis RE et al (2009) A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response. J Infect 59:134\u2013138. https:\/\/doi.org\/10.1016\/j.jinf.2009.06.002","journal-title":"J Infect"},{"key":"7160_CR45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/jof6030173","volume":"6","author":"DEVK Monta\u00f1o","year":"2020","unstructured":"Monta\u00f1o DEVK (2020) Host immune defense upon fungal infections with mucorales: pathogen-immune cell interactions as drivers of inflammatory responses. J Fungi 6:173. https:\/\/doi.org\/10.3390\/jof6030173","journal-title":"J Fungi"},{"key":"7160_CR46","doi-asserted-by":"publisher","first-page":"944.e9","DOI":"10.1016\/j.cmi.2019.11.021","volume":"26","author":"A Patel","year":"2020","unstructured":"Patel A, Kaur H, Xess I et al (2020) A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect 26:944.e9-944.e15. https:\/\/doi.org\/10.1016\/j.cmi.2019.11.021","journal-title":"Clin Microbiol Infect"},{"key":"7160_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.23937\/2378-3656\/1410207","volume":"1","author":"T Rabab","year":"2018","unstructured":"Rabab T, Talal A, Nizar bahabri HA (2018) Rhino-orbito-cerebral Mucormycosis in immunocompetent young patient: case report. Clin Med Rev Case Rep 1:5. https:\/\/doi.org\/10.23937\/2378-3656\/1410207","journal-title":"Clin Med Rev Case Rep"},{"key":"7160_CR48","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/JOCS.15332","volume":"36","author":"K Panchanatheeswaran","year":"2021","unstructured":"Panchanatheeswaran K, Ram D, Prasad S et al (2021) Thoracic mucormycosis in immunocompetent patients. J Card Surg 36:1183\u20131188. https:\/\/doi.org\/10.1111\/JOCS.15332","journal-title":"J Card Surg"},{"key":"7160_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/J.BBI.2021.08.005","volume":"97","author":"J JY Ong","year":"2021","unstructured":"JY Ong J, Chan CY, Sharma A et al (2021) The mucormycosis epidemic within COVID-19 pandemic- lessons from India. Brain Behav Immun 97:4. https:\/\/doi.org\/10.1016\/J.BBI.2021.08.005","journal-title":"Brain Behav Immun"},{"key":"7160_CR50","doi-asserted-by":"publisher","first-page":"402","DOI":"10.2310\/7070.2005.34607","volume":"34","author":"SR Sridhara","year":"2005","unstructured":"Sridhara SR, Paragache G, Panda NK, Chakrabarti A (2005) Mucormycosis in immunocompetent individuals: an increasing trend. J Otolaryngol 34:402\u2013406. https:\/\/doi.org\/10.2310\/7070.2005.34607","journal-title":"J Otolaryngol"},{"key":"7160_CR51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12890-021-01504-8","volume":"21","author":"J He","year":"2021","unstructured":"He J, Sheng G, Yue H et al (2021) Isolated pulmonary mucormycosis in an immunocompetent patient: a case report and systematic review of the literature. BMC Pulm Med 21:138. https:\/\/doi.org\/10.1186\/s12890-021-01504-8","journal-title":"BMC Pulm Med"},{"key":"7160_CR52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jcrc.2019.12.012","volume":"56","author":"YQ Huang","year":"2020","unstructured":"Huang YQ, Tremblay JA, Chapdelaine H et al (2020) Pulmonary mucormycosis in a patient with acute liver failure: a case report and systematic review of the literature. J Crit Care 56:89\u201393. https:\/\/doi.org\/10.1016\/j.jcrc.2019.12.012","journal-title":"J Crit Care"},{"key":"7160_CR53","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.mycmed.2018.10.005","volume":"29","author":"J Yang","year":"2019","unstructured":"Yang J, Zhang J, Feng Y et al (2019) A case of pulmonary mucormycosis presented as Pancoast syndrome and bone destruction in an immunocompetent adult mimicking lung carcinoma. J Mycol Med 29:80\u201383. https:\/\/doi.org\/10.1016\/j.mycmed.2018.10.005","journal-title":"J Mycol Med"},{"key":"7160_CR54","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.4103\/jomfp.JOMFP_163_17","volume":"22","author":"D Venkatesh","year":"2018","unstructured":"Venkatesh D, Dandagi S, Chandrappa P, Hema KN (2018) Mucormycosis in immunocompetent patient resulting in extensive maxillary sequestration. J Oral Maxillofac Pathol 22:S112\u2013S116. https:\/\/doi.org\/10.4103\/jomfp.JOMFP_163_17","journal-title":"J Oral Maxillofac Pathol"},{"key":"7160_CR55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/0022-3859.41805","volume":"54","author":"B Shiva Prasad","year":"2008","unstructured":"Shiva Prasad B, Shenoy A, Nataraj K (2008) Primary gastrointestinal mucormycosis in an immunocompetent person. J Postgrad Med 54:211\u2013213. https:\/\/doi.org\/10.4103\/0022-3859.41805","journal-title":"J Postgrad Med"},{"key":"7160_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-020-01202-5","volume":"20","author":"AB Wotiye","year":"2020","unstructured":"Wotiye AB, Ks P, Ayele BA (2020) Invasive intestinal mucormycosis in a 40-year old immunocompetent patient - A rarely reported clinical phenomenon: a case report. BMC Gastroenterol 20:1\u20136. https:\/\/doi.org\/10.1186\/s12876-020-01202-5","journal-title":"BMC Gastroenterol"},{"key":"7160_CR57","doi-asserted-by":"publisher","unstructured":"Pilmis B, Alanio A, Lortholary O, Lanternier F (2018) Recent advances in the understanding and management of mucormycosis.\u00a0F1000Research\u00a0https:\/\/doi.org\/10.12688\/f1000research.15081.1","DOI":"10.12688\/f1000research.15081.1"},{"key":"7160_CR58","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1093\/mmy\/myx101","volume":"56","author":"A Skiada","year":"2018","unstructured":"Skiada A, Lass-Floerl C, Klimko N et al (2018) Challenges in the diagnosis and treatment of mucormycosis. Med Mycol 56:S93\u2013S101. https:\/\/doi.org\/10.1093\/mmy\/myx101","journal-title":"Med Mycol"},{"key":"7160_CR59","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.3390\/ANTIBIOTICS10111308","volume":"10","author":"S Mohammed","year":"2021","unstructured":"Mohammed S, Asdaq B, Rajan A et al (2021) Identifying Mucormycosis severity in Indian COVID-19 patients: a nano-based diagnosis and the necessity for critical therapeutic intervention. Antibiotics 10:1308. https:\/\/doi.org\/10.3390\/ANTIBIOTICS10111308","journal-title":"Antibiotics"},{"key":"7160_CR60","unstructured":"Correia F (2021) Fungo negro: Brasil j\u00e1 tem 29 casos da doen\u00e7a em 2021 - Olhar Digital. In: https:\/\/olhardigital.com.br\/2021\/06\/01\/medicina-e-saude\/fungo-negro-brasil-ja-tem-29-casos-da-doenca-em-2021\/. https:\/\/olhardigital.com.br\/2021\/06\/01\/medicina-e-saude\/fungo-negro-brasil-ja-tem-29-casos-da-doenca-em-2021\/. Accessed 31 Dec 2021"},{"key":"7160_CR61","first-page":"210","volume":"4","author":"P Badiee","year":"2012","unstructured":"Badiee P, Jafarpour Z, Alborzi A et al (2012) Orbital mucormycosis in an immunocompetent individual. Iran J Microbiol 4:210","journal-title":"Iran J Microbiol"},{"key":"7160_CR62","doi-asserted-by":"publisher","first-page":"42","DOI":"10.9790\/0853-1804154245","volume":"18","author":"NP Das","year":"2019","unstructured":"Das NP, Varma S, N NM (2019) Mucormycosis-a rare case report. IOSR J Dent Med Sci e-ISSN 18:42\u201345. https:\/\/doi.org\/10.9790\/0853-1804154245","journal-title":"IOSR J Dent Med Sci e-ISSN"},{"key":"7160_CR63","unstructured":"Chalmers V (2021) Deadly \u2018black fungus\u2019 rotting Covid patients\u2019 organs - everything you need to know. US SUN"},{"key":"7160_CR64","unstructured":"Pandula V (2021) Oral symptoms of Mucormycosis \u2013 diagnosis and treatment. In: Jr Dent. https:\/\/www.juniordentist.com\/oral-symptoms-of-mucormycosis-diagnosis-treatment.html. Accessed 31 Dec 2021"},{"key":"7160_CR65","unstructured":"Kellkar J (2021) Mucormycosis. In: https:\/\/www.nioeyes.com\/2021\/05\/25\/what-is-mucormycosis\/. https:\/\/www.nioeyes.com\/2021\/05\/25\/what-is-mucormycosis\/. Accessed 31 Dec 2021"},{"key":"7160_CR66","first-page":"52","volume":"4","author":"A Soni","year":"2017","unstructured":"Soni A (2017) Paranasal mucormycosis in an immunocompetent individual: Importance of early diagnosis. Int J Oral Heal Med 4:52\u201356","journal-title":"Int J Oral Heal Med"},{"key":"7160_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof4030090","volume":"4","author":"NV Sipsas","year":"2018","unstructured":"Sipsas NV, Gamaletsou MN, Anastasopoulou A, Kontoyiannis DP (2018) Therapy of mucormycosis. J Fungi 4:1\u201317. https:\/\/doi.org\/10.3390\/jof4030090","journal-title":"J Fungi"},{"key":"7160_CR68","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1093\/cid\/cir885","volume":"54","author":"B Spellberg","year":"2012","unstructured":"Spellberg B, Ibrahim A, Roilides E et al (2012) Combination therapy for mucormycosis: Why, what, and how? Clin Infect Dis 54:S73\u2013S78. https:\/\/doi.org\/10.1093\/cid\/cir885","journal-title":"Clin Infect Dis"},{"key":"7160_CR69","doi-asserted-by":"publisher","unstructured":"Skiada A, Lanternier F, Groll AH et al (2013) Diagnosis and treatment of mucormycosis in patients with hematological malignancies: Guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica 98:492\u2013504. https:\/\/doi.org\/10.3324\/haematol.2012.065110","DOI":"10.3324\/haematol.2012.065110"},{"key":"7160_CR70","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","volume":"19","author":"OA Cornely","year":"2019","unstructured":"Cornely OA, Alastruey-Izquierdo A, Arenz D et al (2019) Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis 19:e405\u2013e421. https:\/\/doi.org\/10.1016\/S1473-3099(19)30312-3","journal-title":"Lancet Infect Dis"},{"key":"7160_CR71","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1473-3099(16)30541-2","volume":"17","author":"D Grimaldi","year":"2017","unstructured":"Grimaldi D, Pradier O, Hotchkiss RS, Vincent JL (2017) Nivolumab plus interferon-\u03b3 in the treatment of intractable mucormycosis. Lancet Infect Dis 17:18. https:\/\/doi.org\/10.1016\/S1473-3099(16)30541-2","journal-title":"Lancet Infect Dis"},{"key":"7160_CR72","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1086\/589857","volume":"47","author":"C Reed","year":"2008","unstructured":"Reed C, Bryant R, Ibrahim AS et al (2008) Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 47:364\u2013371. https:\/\/doi.org\/10.1086\/589857","journal-title":"Clin Infect Dis"},{"key":"7160_CR73","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ijantimicag.2019.01.002","volume":"53","author":"W Jeong","year":"2019","unstructured":"Jeong W, Keighley C, Wolfe R et al (2019) Contemporary management and clinical outcomes of mucormycosis: a systematic review and meta-analysis of case reports. Int J Antimicrob Agents 53:589\u2013597. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.01.002","journal-title":"Int J Antimicrob Agents"},{"key":"7160_CR74","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2147\/IMCRJ.S279495","volume":"13","author":"H Jung","year":"2020","unstructured":"Jung H, Kim GJ, Oh TH (2020) Successful management of a rare gastric mucormycosis presenting with massive melena in a polytrauma patient. Int Med Case Rep J 13:531\u2013535. https:\/\/doi.org\/10.2147\/IMCRJ.S279495","journal-title":"Int Med Case Rep J"},{"key":"7160_CR75","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/J.IJBIOMAC.2021.07.156","volume":"187","author":"A Singh","year":"2021","unstructured":"Singh A, Ahmad N, Varadarajan A et al (2021) Lactoferrin, a potential iron-chelator as an adjunct treatment for mucormycosis \u2013 a comprehensive review. Int J Biol Macromol 187:988\u2013998. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2021.07.156","journal-title":"Int J Biol Macromol"},{"key":"7160_CR76","doi-asserted-by":"publisher","first-page":"101567","DOI":"10.1016\/J.CSITE.2021.101567","volume":"28","author":"MA William","year":"2021","unstructured":"William MA, Su\u00e1rez-L\u00f3pez MJ, Soutullo S, Hanafy AA (2021) Evaluating heating, ventilation, and air-conditioning systems toward minimizing the airborne transmission risk of Mucormycosis and COVID-19 infections in built environment. Case Stud Therm Eng 28:101567. https:\/\/doi.org\/10.1016\/J.CSITE.2021.101567","journal-title":"Case Stud Therm Eng"},{"key":"7160_CR77","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.3390\/CELLS10113014","volume":"10","author":"MA Soltan","year":"2021","unstructured":"Soltan MA, Eldeen MA, Elbassiouny N et al (2021) In silico designing of a multitope vaccine against rhizopus microsporus with potential activity against other mucormycosis causing fungi. Cells 10:3014. https:\/\/doi.org\/10.3390\/CELLS10113014","journal-title":"Cells"},{"key":"7160_CR78","first-page":"82","volume":"52","author":"SM Betharia","year":"2004","unstructured":"Betharia SM, Wagh VB, Pathak H et al (2004) Rhino-orbital-cerebral mucormycosis. A retrospective analysis and treatment option. Indian J Ophthalmol 52:82\u201383","journal-title":"Indian J Ophthalmol"},{"key":"7160_CR79","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/cid\/cir866","volume":"54","author":"G Petrikkos","year":"2012","unstructured":"Petrikkos G, Skiada A, Lortholary O et al (2012) Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 54:S23\u2013S34. https:\/\/doi.org\/10.1093\/cid\/cir866","journal-title":"Clin Infect Dis"},{"key":"7160_CR80","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2217\/fmb.13.78","volume":"8","author":"REKD Lewis","year":"2013","unstructured":"Lewis REKD (2013) Epidemiology and treatment of mucormycosis external icon. Future Microbiol 8:1163\u20131175","journal-title":"Future Microbiol"},{"key":"7160_CR81","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1183\/09031936.96.09081751","volume":"9","author":"W von Pohle","year":"1996","unstructured":"von Pohle W (1996) Disseminated mucormycosis presenting with lower extremity weakness. Eur Respir J 9:1751\u20131753","journal-title":"Eur Respir J"},{"key":"7160_CR82","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1590\/abd1806-4841.20176614","volume":"92","author":"AD Castrej\u00f3n-P\u00e9rez","year":"2017","unstructured":"Castrej\u00f3n-P\u00e9rez AD, Miranda I, Welsh O et al (2017) Cutaneous mucormycosis. An Bras Dermatol 92:304\u2013311. https:\/\/doi.org\/10.1590\/abd1806-4841.20176614","journal-title":"An Bras Dermatol"},{"key":"7160_CR83","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1128\/CMR.13.2.236-301.2000","volume":"13","author":"JA Ribes","year":"2000","unstructured":"Ribes JA, Vanover-Sams CL, Baker DJ (2000) Zygomycetes in human disease. Clin Microbiol Rev 13:236\u2013301. https:\/\/doi.org\/10.1128\/CMR.13.2.236-301.2000","journal-title":"Clin Microbiol Rev"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07160-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07160-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07160-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T18:32:59Z","timestamp":1657218779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07160-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":83,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["7160"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07160-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"assertion":[{"value":"11 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no conflicts of interest to declare that they are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}